Recent Security Class Actions

uniQure N.V. Ordinary Shares (NASDAQ: QURE)

31 Days left to seek lead plaintiff status.

Company Name:uniQure N.V. Ordinary Shares
Stock Symbol:NASDAQ: QURE
Class Period Start:09/24/2025
Class Period End (inclusive):10/31/2025
Filing Deadline:04/13/2026

The complaint alleges defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the Company’s business and operations. Specifically, Defendants misrepresented and/or failed to disclose that: (1) the design of uniQure’s Pivotal Study—including comparison of the Pivotal Study results to the ENROLL-HD external historical data set—was not fully approved by the FDA; (2) Defendants downplayed the likelihood that, despite purportedly highly successful results from the Pivotal Study, uniQure would have to delay its BLA timeline to perform additional studies to supplement its BLA submission; and (3) as a result, Defendants’ statements about the Company’s business, operations, and prospects lacked a reasonable basis.

uniQure N.V. Ordinary Shares (NASDAQ: QURE) Claim Form

This field is for validation purposes and should be left unchanged.
Name(Required)
Address